Nynomic AG
ISIN: DE000A0MSN11
WKN: A0MSN1
09 May 2025 09:01AM

Original-Research: Nynomic AG (von NuWays AG): BUY

Nynomic AG · ISIN: DE000A0MSN11 · EQS - Analysts
Country: Germany · Primary market: Germany · EQS NID: 22524

Original-Research: Nynomic AG - from NuWays AG

09.05.2025 / 09:01 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Nynomic AG

Company Name: Nynomic AG
ISIN: DE000A0MSN11
 
Reason for the research: Update
Recommendation: BUY
from: 09.05.2025
Target price: EUR 34.50
Target price on sight of: 12 months
Last rating change:
Analyst: Christian Sandherr

Muted start into the year; gradual improvements expected

Topic: Nynomic published a muted start into FY25, largely the result of the ongoing uncertainty within its key end markets. Yet, management remains confident to be able to record gradual improvements throughout the year.

Preliminary sales in Q1 declined by 10% yoy to € 20.6m due to unchanged wait-and-see attitude of customers and situation-related investment postponements, particularly in the semiconductor industry. As a result of the weak operating leverage, preliminary Q1 EBIT turned negative at € -0.9m (vs € 1.6m in Q1 2024).

Order backlog down yoy due to fundamentally changed order behaviour. In particular, larger OEM customers have adjusted their ordering patterns in response to increased market uncertainty and reduced predictability. Instead of placing long-term blanket orders for 12 or 24 months, they are increasingly opting for shorter-term orders, such as on a quarterly basis. The € 45m order backlog at the end of Q1 (-24% yoy) is hence no major reason for concern, in our view.

FY25 guidance remains unchanged. Management continues to expect € 105-110m sales (eNuW: € 108m) and € 8.5-10m EBIT (eNuW: € 9.1m) for the full year, carried by sequential improvements throughout the year, a well filled product pipeline, recent product launches, improving demand from core markets such as semiconductors, med-tech and pharma but also delayed orders materializing.

Importantly, management reaffirmed its mid-term targets of €200m in sales and a 16–19% EBIT margin within 3-5 years, driven by organic growth and strategic acquisitions. This dual strategy positions Nynomic to capitalize on rising industry demand and enter a promising growth phase.

While the Q1 results reflect a challenging start into 2025, we take comfort from the solid order backlog and management’s confidence in catching up over the year. Structural measures should support margin expansion beyond 2025. While the short-term visibility remains limited due to volatile customer ordering patterns, the long-term prospects remain unchanged, which is not reflected in the depressed valuation. We hence confirm our BUY rating with an unchanged € 34.5 PT based on DCF.

You can download the research here: http://www.more-ir.de/d/32524.pdf
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


2133672  09.05.2025 CET/CEST

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2019 2020 2021 2022 2023 2024 2025e
Sales1 64,86 78,56 105,08 116,79 117,99 102,42 102,50
EBITDA1,2 9,55 11,43 17,00 19,18 20,22 15,51 7,00
EBITDA-Margin3 14,72 14,55 16,18 16,42 17,14 15,14 6,83
EBIT1,4 6,43 7,97 12,99 15,08 15,43 7,39 2,00
EBIT-Margin5 9,91 10,15 12,36 12,91 13,08 7,22 1,95
Net Profit (Loss)1 4,30 5,18 9,52 9,95 10,53 -0,27 -0,15
Net-Margin6 6,63 6,59 9,06 8,52 8,92 -0,26 -0,15
Cashflow1,7 3,56 6,37 17,83 9,68 3,17 7,79 6,80
Earnings per share8 0,87 0,83 1,37 1,26 1,47 -0,10 -0,02
Dividend per share8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: Dr. Clauß, Dr. Paal & Partner

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Nynomic
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
A0MSN1 DE000A0MSN11 AG 72,45 Mio € 02.07.2007 Halten 9F5FHPV5+7C
* * *
PE 2026e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
15,71 22,93 0,69 10,97 0,74 9,29 0,71
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
0,00 0,00 0,00 0,00%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
08.07.2025 08.05.2025 12.08.2025 28.11.2025 22.05.2025
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
-3,93%
11,00 €
ATH 56,40 €
+2,52% -12,13% -37,50% -37,85% +7,32%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL